SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
597Abbott Laboratories Licenses Protein Design Labs' Intellectual Property for scaram(o)uche-12/23/2003
596Seattle Genetics Announces That Protein Design Labs Has Taken An Exclusive Antigscaram(o)uche-12/23/2003
595Repeat: Pfizer Deal MorphoSys' Biggest Upfront Payment Monday December 22, 5nigel bates-12/22/2003
594MorphoSys Enters Antibody Collaboration With Pfizer Monday December 22, 1:47 am Icebrg-12/22/2003
593>>Published online before print December 19, 2003 Proc. Natl. Acad. Sci. Utuck-12/19/2003
592>> how nice it would be to use some else's money << and regulatscaram(o)uche-12/18/2003
591<i>These 25% or 30% deals are great.</i> Yeah. That's why, fromkeokalani'nui-12/18/2003
590<i>XOMA continues to play on strength</i> Almost tempting at this lnigel bates-12/18/2003
589XOMA continues to play on strength, the realm of Butch Dellio..... operationscaram(o)uche-12/18/2003
588Alexion Pharmaceuticals and XOMA Form Collaboration Thursday December 18, 6:30 aIcebrg-12/18/2003
587Morphotek Announces Successful Development of Antibody Cell Line For Abgenix &nigel bates-12/16/2003
586This is the old MRC Collaboration Centre. mrctechnology.org I haven't beenscaram(o)uche-12/11/2003
585Just parking (hadn't noticed them before): aeresbiomedical.com AERES is renigel bates-12/11/2003
584Thursday November 27, 4:32 am ET (that's 2003)scaram(o)uche-11/29/2003
583>>Eos? PDLI?>> That PR was issued before Eos had been taken over. Icebrg-11/29/2003
582Nigel, why do you just target IMGN. To my way of thinking anything positive shoGary Mohilner-11/28/2003
581Maybe they didn't like appearing on the same list as Xoma ?nigel bates-11/28/2003
580yup, Eos. wonder if they were going to insert PDLI and forgot, or if PDLI wantsscaram(o)uche-11/28/2003
579<i>Centocor Inc. (Malvern, Pennsylvania/USA), California/USA), GPC Biotechscaram(o)uche-11/28/2003
578<i>This (Glycart) looks interesting (IMGN shareholders might find it distunigel bates-11/28/2003
577MorphoSys Issued U.S. Patent for HuCAL(R) EST Technology Thursday November 27, 4nigel bates-11/27/2003
576The Scientist provides an overview of the Mab space. Not likely to contain anyttuck-11/20/2003
575Boehringer Excercises MorphoSys Antibody Option Tuesday November 18, 2:25 am ET nigel bates-11/18/2003
574Boehringer Excercises MorphoSys Antibody Option Tuesday November 18, 2:25 am ET Icebrg-11/18/2003
573PIERIS Announces Breakthrough in Anticalin(R) Technology Human ANTICALIN(R) withnigel bates-11/18/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News